institutionalization of production safety
Release time:
2020-08-14
Institutionalization of production safety
In the work of production safety, we have the courage to practice, establish and improve safety rules and regulations, and resolutely achieve "use rules and regulations to restrain people, use systems to regulate people, and use mechanisms to manage people". Only in this way can we ensure the institutionalization, standardization and standardization of production safety.
In order to further enhance the ability of accident prevention and emergency treatment, Yunnan Jianfeng organized and carried out 6 on-site disposal plan drills for production safety accidents in the first half of the year. At the same time, it revised special emergency plan drills including prevention of major casualties, power failure of the whole plant, boiler leakage, overload of electric control cabinet and fire, woven bag warehouse fire, nature of coal storage yard, fire safety and other aspects, detailed terms are convenient for learning, detailed contents are convenient for operation, detailed training is strengthened for drills, and through paying attention to a series of "details", the emergency handling ability of production personnel in front of emergencies is enhanced.
is to strengthen safety supervision and realize controllable, controllable and controlled safety production. Yunnan Jianfeng requires all employees to participate in on-site safety management, effectively strengthen the implementation of the responsibilities of safety management personnel at all levels and the supervision and implementation of safety management personnel at all levels on the job site, use the "three railways" to oppose the "three violations" and eliminate the "three high" ", forming a good atmosphere of" safety supervision is everyone's responsibility and safety supervision is in place. At the same time, enterprises must also give full play to the role of safety supervision network and carry out in-depth anti-habitual violation activities. Every large, medium and small maintenance work, all external repair teams must be subject to the "temporary admission safety notice" before maintenance work, full-time and part-time safety supervision personnel at all levels in accordance with the "in place standard", strictly implement all kinds of "work license" examination and approval system, further clarify the safety responsible person and safety measures, and at the same time in-depth on-site supervision and control, check every link in detail, and stop the unsafe behavior of operators in time, strict investigation and punishment have alerted violators and educated employees.
The development of these activities has effectively enhanced the safety awareness and self-prevention ability of employees, played a role in reducing violations at work, and achieved the purpose of controlling minor injuries to personnel and above personal accidents and controlling man-made liability equipment accidents. (Liu Fengbin)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page